INOTIV, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.05 USD | -5.59% |
|
-6.25% | +10.35% |
| 03-19 | Inotiv, Inc. Elects Michael J. Harrington as Class III Member of the Board | CI |
| 02-12 | North American Morning Briefing : Stock Futures -2- | DJ |
Chart calendar Inotiv, Inc.
d235b0758752b88286.UfYU7hQjN6h4mOa6Mgg6TVyt6q843ZijsoI5rtaTEbo.Ppxbq04aBNI5qbPiYWV_eTKcm_dSkf-bxOlInKyjaOk8g3i2JXVvhSzNkQ~997559b930d318dfa428c7ca9eb33147
Upcoming events on Inotiv, Inc.
Past events on Inotiv, Inc.
| 14/03/2024 14:00 | Annual General Meeting |
| 07/02/2024 21:30 | Q1 2024 Earnings Call |
| 07/02/2024 21:05 | Q1 2024 Earnings Release |
| 11/12/2023 21:30 | Q4 2023 Earnings Call |
| 11/12/2023 21:05 | Q4 2023 Earnings Release |
| 29/11/2023 20:00 | Evercore ISI HealthCONx Conference |
| 16/11/2023 13:00 | Craig-Hallum Alpha Select Conference |
| 15/11/2023 16:00 | Jefferies London Healthcare Conference |
| 13/09/2023 | Lakestreet Best Ideas Growth Conference |
| 13/09/2023 16:25 | Baird Global Healthcare Conference |
| 08/09/2023 13:45 | Wells Fargo Healthcare Conference |
| 16/08/2023 | Investor Meeting |
| 10/08/2023 21:30 | Q3 2023 Earnings Call |
| 10/08/2023 21:08 | Q3 2023 Earnings Release |
| 31/07/2023 | Investor Meeting |
| 09/06/2023 13:30 | Jefferies Global Healthcare Conference |
| 30/05/2023 | Craig-Hallum Institutional Investor Conference |
| 22/05/2023 | Benchmark Healthcare House Call Conference |
| 11/05/2023 21:30 | Q2 2023 Earnings Call |
| 11/05/2023 21:05 | Q2 2023 Earnings Release |
Annual results
| Fiscal Period | September | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 60,5 | 89,6 89,6 -0.03% | 548 548 -0.01% | 572 571 0.23% | 581 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 9,32 6,10 52.69% | 90,5 96,0 -5.76% | 65,8 61,5 7.08% | 76,7 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -5,62 -3,62 -55.3% | -263 -23,5 -1020.76% | -81,5 -52,0 -56.7% | 6,52 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 6,12 -5,10 220.02% | -352 -110 -220.56% | -124 -127 2.36% | -35,4 |
|
Net income Million USD | Released Forecast Spread | 0,00 | 10,9 -5,32 304.97% | -337 -102 -228.8% | -105 -104 -0.94% | -29,8 |
|
EPS USD | Released Forecast Spread | -0,43 | 0,19 -0,40 148.1% | -13,8 -4,20 -229.52% | -4,10 -4,03 -1.86% | -1,15 |
| Announcement Date | 21/12/20 | 16/12/21 | 10/01/23 | 11/12/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 84,2 72,8 15.7% | 140 121 16.39% | 173 142 21.83% | 150 151 -0.02% | 123 124 -0.8% | 151 138 9.55% | 157 151 4.23% | 141 139 0.94% | 136 133 1.98% | 136 | 151 | 158 | 142 | 143 |
|
EBITDA Million USD | Released Forecast Spread | 10,1 8,34 21.33% | 25,3 15,1 67.15% | 37,0 22,1 67.29% | 18,3 23,7 -22.91% | -5,48 -2,03 -170.36% | 17,1 14,4 18.5% | 30,5 24,9 22.51% | 23,7 19,2 23.61% | 9,62 8,33 15.45% | 12,2 | 24,9 | 30,1 | 13,8 | 14,3 |
|
EBIT Million USD | Released Forecast Spread | -33,6 2,40 -1499.18% | 7,87 -0,91 969.39% | 4,79 6,91 -30.74% | -242 -2,51 -9546.55% | -90,6 -25,3 -257.34% | -2,13 -0,27 -694.39% | 8,78 8,96 -2.01% | 2,46 3,07 -19.77% | -9,37 -13,0 27.75% | -4,29 | 8,22 | 11,9 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -96,2 -0,74 -12841.22% | 0,18 -6,50 102.8% | -3,21 -0,71 -351.72% | -253 -10,7 -2259.06% | -103 -36,1 -185.3% | -12,1 -11,6 -3.89% | -2,02 -2,37 14.96% | -7,23 -10,2 29.44% | -19,3 -24,3 20.33% | -15,0 | -2,40 | 1,25 | ||
|
Net income Million USD | Released Forecast Spread | -83,0 -0,98 -8359.77% | -6,09 -6,37 4.45% | -3,73 -0,54 -587.82% | -244 -9,67 -2425.27% | -87,3 -31,9 -173.4% | -9,99 -11,0 8.95% | 1,84 -2,56 171.76% | -9,66 -8,73 -10.74% | -15,4 -22,1 30.33% | -13,9 | -2,13 | 1,63 | ||
|
EPS USD | Released Forecast Spread | -3,93 -0,04 -8969.93% | -0,24 -0,27 11.11% | -0,15 -0,02 -650% | -9,54 -0,38 -2444% | -3,41 -1,30 -162.31% | -0,39 -0,43 8.24% | 0,07 -0,10 170% | -0,38 -0,33 -15.15% | -0,60 -0,86 29.82% | -0,54 | -0,09 | 0,07 | ||
| Announcement Date | 10/02/22 | 12/05/22 | 10/08/22 | 10/01/23 | 13/02/23 | 11/05/23 | 10/08/23 | 11/12/23 | 07/02/24 | - | - | - | - | - |
More events
Past sector events for Inotiv, Inc.
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 06:00 | BB BIOTECH AG: Q1 2024 Earnings Release |
| 25/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 25/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 25/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 12:00 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 07:00 | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOTV Stock
- Calendar Inotiv, Inc.
